| Dr Brian Kiesnowski, MD | |
|
5605 Waterford Ln, Appleton, WI 54913-8438 | |
| (920) 738-7200 | |
| (920) 738-1906 |
| Full Name | Dr Brian Kiesnowski |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 32 Years |
| Location | 5605 Waterford Ln, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285607317 | NPI | - | NPPES |
| 32627900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 41995-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appleton Plastic Surgery Center, Sc | 3072553205 | 2 |
News Archive
Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.
A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.
Good news for cat lovers! A latest study has found that a parasite infestation found in cat feces could make a person an entrepreneur. Cat feces commonly contain parasite Toxoplasma gondii and its infection can often go unnoticed in most individuals. A new study has found that people who have had T. gondii infection are around 1.4 times more likely to major in business studies compared to those who were not infected.
Employers in the United States have become less satisfied with their health insurers, according to a study released today by PricewaterhouseCoopers' Health Research Institute. Hit hard by the recession, employers of all sizes are taking a critical look at their health benefits strategy and the value they derive from it. They are looking to their health plan providers for information, technology and strategies to help reduce waste in healthcare spending and better engage employees in managing their health.
Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 5 days ago
| Entity Name | Appleton Plastic Surgery Center, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235246869 PECOS PAC ID: 3072553205 Enrollment ID: O20050506000697 |
News Archive
Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.
A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.
Good news for cat lovers! A latest study has found that a parasite infestation found in cat feces could make a person an entrepreneur. Cat feces commonly contain parasite Toxoplasma gondii and its infection can often go unnoticed in most individuals. A new study has found that people who have had T. gondii infection are around 1.4 times more likely to major in business studies compared to those who were not infected.
Employers in the United States have become less satisfied with their health insurers, according to a study released today by PricewaterhouseCoopers' Health Research Institute. Hit hard by the recession, employers of all sizes are taking a critical look at their health benefits strategy and the value they derive from it. They are looking to their health plan providers for information, technology and strategies to help reduce waste in healthcare spending and better engage employees in managing their health.
Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Kiesnowski, MD 5605 Waterford Ln, Appleton, WI 54913-8438 Ph: (920) 738-7200 | Dr Brian Kiesnowski, MD 5605 Waterford Ln, Appleton, WI 54913-8438 Ph: (920) 738-7200 |
News Archive
Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.
A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.
Good news for cat lovers! A latest study has found that a parasite infestation found in cat feces could make a person an entrepreneur. Cat feces commonly contain parasite Toxoplasma gondii and its infection can often go unnoticed in most individuals. A new study has found that people who have had T. gondii infection are around 1.4 times more likely to major in business studies compared to those who were not infected.
Employers in the United States have become less satisfied with their health insurers, according to a study released today by PricewaterhouseCoopers' Health Research Institute. Hit hard by the recession, employers of all sizes are taking a critical look at their health benefits strategy and the value they derive from it. They are looking to their health plan providers for information, technology and strategies to help reduce waste in healthcare spending and better engage employees in managing their health.
Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
› Verified 5 days ago